Johnson & Johnson JNJ
NYSE JNJ
$275.15 -3.32 (-1.19%)
At close: Sep 4, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Short-Term Debt issuances (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Short-Term Debt issuances came in at $707.0 million in Q2 2026, up 25.13% year-over-year from $565.0 million in Q2 2025, and down 94.32% quarter-over-quarter from $12.4 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Short-Term Debt issuances (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Short-Term Debt issuances across 18 years of filings, most recently posting $707.0 million for Q2 2026.

  • In Q2 2026, Short-Term Debt issuances rose 25.13% year-over-year to $707.0 million; the TTM figure through Jun 2026 stood at $18.4 billion (up 72.61% YoY), while the FY2025 annual figure was $14.6 billion, down 4.52% from the prior year.
  • Short-Term Debt issuances came in at $707.0 million for Q2 2026 at Johnson & Johnson, down from $12.4 billion in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $14.9 billion in Q1 2023 to a low of -$2.0 billion in Q3 2024.
  • Average Short-Term Debt issuances over 5 years is $5.2 billion, with a median of $3.6 billion recorded in 2024.
  • Year-over-year, Short-Term Debt issuances soared 535.58% in 2022 and plunged 124.79% in 2024.
  • Over 5 years, Short-Term Debt issuances stood at $3.0 billion in 2022, then tumbled by 56.01% to $1.3 billion in 2023, then soared by 147.97% to $3.3 billion in 2024, then gained by 18.83% to $3.9 billion in 2025, then sank by 81.93% to $707.0 million in 2026.
  • Per Business Quant data, the three most recent Short-Term Debt issuances figures were $707.0 million in Q2 2026, $12.4 billion in Q1 2026, and $3.9 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 707.00 Mn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 4.94 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 208.00 Mn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 64.00 Mn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn -
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
10 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 707.00 Mn
Mar 29, 2026 12.44 Bn
Dec 28, 2025 3.91 Bn
Sep 28, 2025 1.32 Bn
Jun 29, 2025 565.00 Mn
Mar 30, 2025 8.78 Bn
Dec 29, 2024 3.29 Bn
Sep 29, 2024 -1.99 Bn
Jun 30, 2024 8.71 Bn
Mar 31, 2024 5.26 Bn
Dec 31, 2023 1.33 Bn
Oct 1, 2023 8.03 Bn
Jul 2, 2023 2.52 Bn
Apr 2, 2023 11.09 Bn
Jan 1, 2023 14.85 Bn
Apr 3, 2022 3.02 Bn
Oct 3, 2021 594.00 Mn
Jul 4, 2021 214.00 Mn
Apr 4, 2021 475.00 Mn
Jan 3, 2021 56.00 Mn